TY - JOUR
T1 - HMAMP
T2 - Designing Highly Potent Antimicrobial Peptides Using a Hypervolume-Driven Multiobjective Deep Generative Model
AU - Wang, Li
AU - Liu, Yiping
AU - Fu, Xiangzheng
AU - Ye, Xiucai
AU - Shi, Junfeng
AU - Yen, Gary G.
AU - Zou, Quan
AU - Zeng, Xiangxiang
AU - Cao, Dongsheng
N1 - This work was supported by the National Natural Science Foundation of China (U22A2037, 62425204, 62450002,62432011, 662002111, 62372158, 62472152, 62106073, 62122025, 62250028), and the Hunan Provincial Natural Science Foundation of China (Grant Nos. 2022JJ40090, 2024JJ4015).
Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025/4/24
Y1 - 2025/4/24
N2 - Antimicrobial peptides (AMPs) have exhibited unprecedented potential as biomaterials in combating multidrug-resistant bacteria, prompting the proposal of many excellent generative models. However, the multiobjective nature of AMP discovery is often overlooked, contributing to the high attrition rate of drug candidates. Here, we propose a novel approach termed hypervolume-driven multiobjective AMP design (HMAMP), which prioritizes the simultaneous optimization of multiattribute AMPs. By synergizing reinforcement learning and a gradient descent algorithm rooted in the hypervolume maximization concept, HMAMP effectively biases generative processes and mitigates the pattern collapse issue. Comparative experiments show that HMAMP significantly outperforms state-of-the-art methods in effectiveness and diversity. A knee-based decision strategy is then employed to fast screen candidates with favorable physicochemical properties, aligning with the enhanced antimicrobial activity and reduced side effects. Molecular visualization further elucidates structural and functional properties of the AMPs. Overall, HMAMP is an effective approach to traverse large and complex exploration spaces to search for idealism-realism trade-off AMPs.
AB - Antimicrobial peptides (AMPs) have exhibited unprecedented potential as biomaterials in combating multidrug-resistant bacteria, prompting the proposal of many excellent generative models. However, the multiobjective nature of AMP discovery is often overlooked, contributing to the high attrition rate of drug candidates. Here, we propose a novel approach termed hypervolume-driven multiobjective AMP design (HMAMP), which prioritizes the simultaneous optimization of multiattribute AMPs. By synergizing reinforcement learning and a gradient descent algorithm rooted in the hypervolume maximization concept, HMAMP effectively biases generative processes and mitigates the pattern collapse issue. Comparative experiments show that HMAMP significantly outperforms state-of-the-art methods in effectiveness and diversity. A knee-based decision strategy is then employed to fast screen candidates with favorable physicochemical properties, aligning with the enhanced antimicrobial activity and reduced side effects. Molecular visualization further elucidates structural and functional properties of the AMPs. Overall, HMAMP is an effective approach to traverse large and complex exploration spaces to search for idealism-realism trade-off AMPs.
UR - http://www.scopus.com/inward/record.url?scp=105003471352&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.4c03073
DO - 10.1021/acs.jmedchem.4c03073
M3 - Journal article
AN - SCOPUS:105003471352
SN - 0022-2623
VL - 68
SP - 8346
EP - 8360
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 8
ER -